Overview
Legal name
ANGLO BIOPHARMA LIMITED
Region
South East England
Registered address
Unknown
Insolvency history
No
Company
Active
LTD
Company profile
Anglo Biopharma Limited
Anglo Biopharma Limited is a UK company with status active founded in 2016 based in South East England.
CRN
10127664
Founded
2016
Age
7
Company events
Reference milestones and recent Companies House filing stream events.
1 event
15 Apr
2016
Incorporated
InceptionCompany registered at Companies House
Public funding
2 awards
First funded
2017
Funded years
2017, 2018
Age at first award
0 years
Projects
2018
Feasibility Studies
Lead participant
mAb manufacturing for future subunit vaccine platform
1 Mar 2018 to 28 Feb 2019
Awarded
£21,234
Total cost £30,334
A platform for rapidly producing rationally engineered vaccines is urgently required to combat the threat of epidemic or pandemic pathogen outbreaks. Most existing vaccines are multicomponent products that are challenging to manufacture. The slowest step is typically transfer from preclinical proof-of-concept to GMP manufacture for human use. Manufacturin...
2017
Feasibility Studies
Lead participant
Evaluation of the technical & commercial viability of developing an accelerated MERS vaccine
1 Feb 2017 to 31 Jan 2018
Awarded
£70,000
Total cost £100,000
Anglo Biopharma Ltd, a UK based british biotech startup, will assess both the commercial and technical potential of a Middle Eastern Respiratory Syndrome (MERS) vaccine. An evaluation of the commercial viability of a novel MERS vaccine towards MERS will be performed. MERS is a disease described by the director of the World Health Organisation (WHO) as a "...
Product types
Feasibility Studies